ArticleBMC infectious diseases2025
Telemedicine virologic and immunologic outcomes in people living with HIV (PLWH) in a correctional setting during the SARS-CoV-2 pandemic.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt is known that SARS-CoV-2 infection increases the risk of severe illness in patients who are immunocompromised as compared to the general public. To combat this issue, telemedicine was utilized to combat the issue of general access to care to decrease the risk of exposure of SARS-CoV-2 infection in various settings. However, there is very little data on adequate continuity of care (COC) and sustainability of telehealth throughout the SARS-CoV-2 pandemic. There is even less data on the effects of the SARS-CoV-2 pandemic in special populations, such as people living with human immunodeficiency virus (PLWH) who reside in the correctional setting. The purpose of this study was to investigate rates of HIV virologic suppression (VS) and the sustainability of telemedicine throughout the SARS-CoV-2 pandemic.
methodsThis was a retrospective, pre-post cohort study of PLWH who received antiretroviral therapy (ART) within Illinois Department of Corrections (IDOC)/University of Illinois at Chicago telemedicine clinic between March 2019- March 2021. Patients who were released from IDOC or reincarcerated during the study period were excluded. The primary endpoint compared the rate of HIV VS pre-, peri-, and post-SARS-CoV-2 restrictions. Secondary endpoints included change in immunologic function pre-, peri-, and post-SARS-CoV-2 restrictions, incidence of SARS-CoV-2 infection, number of hospitalizations, development of virologic failure, and change in ART post-restriction. Other factors known to influence COC were also collected.
resultsOf 320 patients screened, 225 were included. The majority were Black males (73.7%) where 95.1% had a CD4 T-cell count > 200 cells/mm
conclusionsPLWH within IDOC had sustained VS and COC throughout the SARS-CoV-2 pandemic with telemedicine. These results describe how the pandemic impacted PLWH in a correctional setting and future studies could contribute to creating national guidance for telemedicine models to streamline clinical practice through the utilization of telemedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.